Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.
BACKGROUND:Regular use of inhaled corticosteroids (ICS) in patients with obstructive lung diseases has been associated with a higher risk of pneumonia, particularly in COPD. The risk of pneumonia has not been previously evaluated in relation to ICS particle size and dose used. METHODS:Historical coh...
Main Authors: | Samatha Sonnappa, Richard Martin, Elliot Israel, Dirkje Postma, Wim van Aalderen, Annie Burden, Omar S Usmani, David B Price, Respiratory Effectiveness Group, Small Airways Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5472262?pdf=render |
Similar Items
-
Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD
by: Postma DS, et al.
Published: (2014-10-01) -
The use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics
by: Benfante A, et al.
Published: (2016-10-01) -
Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study
by: Helgo Magnussen, et al.
Published: (2021-01-01) -
Atopy and Inhaled Corticosteroid Use Associate with Fewer IL-17+ Cells in Asthmatic Airways.
by: Fatemeh Fattahi, et al.
Published: (2016-01-01) -
A self-rating scale for patient-perceived side effects of inhaled corticosteroids
by: Dijkstra Antoon, et al.
Published: (2006-10-01)